Product Recalls in California

Product recalls affecting California — including food, drugs, consumer products, medical devices, and vehicles distributed to California. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 3,000 recalls have been distributed to California in the last 12 months.

56,506 total recalls
3,000 in last 12 months

Showing 1070110720 of 13,703 recalls

DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Lisinopril Tablets USP Recalled by Wockhardt Usa Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Metoprolol Succinate Extended-Release Tablets Recalled by Wockhardt Usa Inc....

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Metoprolol Succinate Extended-Release Tablets Recalled by Wockhardt Usa Inc....

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Captopril Tablets Recalled by Wockhardt Usa Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Zonisamide Capsules Recalled by Wockhardt Usa Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Lansoprazole Delayed-Release Capsules Recalled by Wockhardt Usa Inc. Due to...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Azithromycin Tablets Recalled by Wockhardt Usa Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Lisinopril Tablets USP Recalled by Wockhardt Usa Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Lansoprazole Delayed-Release Capsules Recalled by Wockhardt Usa Inc. Due to...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Zolpidem Tartrate Tablets Recalled by Wockhardt Usa Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Lansoprazole Delayed-Release Capsules Recalled by Wockhardt Usa Inc. Due to...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Zonisamide Capsules Recalled by Wockhardt Usa Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Amlodipine Besylate Tablets Recalled by Wockhardt Usa Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Zonisamide Capsules Recalled by Wockhardt Usa Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Captopril Tablets Recalled by Wockhardt Usa Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Metoprolol Succinate Extended-Release Tablets Recalled by Wockhardt Usa Inc....

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Lisinopril Tablets USP Recalled by Wockhardt Usa Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Famotodine Tablets Recalled by Wockhardt Usa Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Lisinopril Tablets USP Recalled by Wockhardt Usa Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 21, 2015· Alvogen, Inc

Recalled Item: NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS CAPSULES Recalled by Alvogen, Inc...

The Issue: Failed Dissolution Specification; 6 month time point

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund